aspartic acid has been researched along with Cardiovascular Diseases in 15 studies
Aspartic Acid: One of the non-essential amino acids commonly occurring in the L-form. It is found in animals and plants, especially in sugar cane and sugar beets. It may be a neurotransmitter.
aspartic acid : An alpha-amino acid that consists of succinic acid bearing a single alpha-amino substituent
L-aspartic acid : The L-enantiomer of aspartic acid.
Cardiovascular Diseases: Pathological conditions involving the CARDIOVASCULAR SYSTEM including the HEART; the BLOOD VESSELS; or the PERICARDIUM.
| Excerpt | Relevance | Reference |
|---|---|---|
| " The main outcome was adverse events [all-cause mortality, cancers, rhabdomylosis, diabetes, aspartate and alanine aminotransferase (AST/ALT), and creatinine kinase (CK) increases beyond the upper limit of normal]." | 2.48 | Adverse events associated with individual statin treatments for cardiovascular disease: an indirect comparison meta-analysis. ( Alberton, M; Briel, M; Druyts, E; Mills, EJ; Wu, P, 2012) |
| "Haemochromatosis is a common genetic disorder, inherited as an autosomal recessive trait that results in a progressive accumulation of iron in most tissues of the body." | 1.31 | Association studies between haemochromatosis gene mutations and the risk of cardiovascular diseases. ( Amarenco, P; Arveiler, D; Cambien, F; Elbaz, A; Evans, A; Gariepy, J; Grandchamp, B; Hetet, G; Kee, F; Morrison, C; Nicaud, V; Simon, A, 2001) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 5 (33.33) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 4 (26.67) | 29.6817 |
| 2010's | 4 (26.67) | 24.3611 |
| 2020's | 2 (13.33) | 2.80 |
| Authors | Studies |
|---|---|
| Wan, X | 1 |
| Jia, W | 1 |
| Wang, Q | 1 |
| Chen, X | 1 |
| Wang, A | 1 |
| Zhu, L | 1 |
| Liu, X | 1 |
| Zhang, L | 1 |
| Zhuang, P | 1 |
| Jiao, J | 1 |
| Zhang, Y | 1 |
| Todisco, S | 1 |
| Musio, B | 1 |
| Pesce, V | 1 |
| Cavalluzzi, MM | 1 |
| Petrosillo, G | 1 |
| La Piana, G | 1 |
| Sgobba, MN | 1 |
| Schlosserová, N | 1 |
| Cafferati Beltrame, L | 1 |
| Di Lorenzo, R | 1 |
| Tragni, V | 1 |
| Marzulli, D | 1 |
| Guerra, L | 1 |
| De Grassi, A | 1 |
| Gallo, V | 1 |
| Volpicella, M | 1 |
| Palese, LL | 1 |
| Lentini, G | 1 |
| Pierri, CL | 1 |
| Chiappelli, J | 1 |
| Rowland, LM | 1 |
| Wijtenburg, SA | 1 |
| Chen, H | 1 |
| Maudsley, AA | 1 |
| Sheriff, S | 1 |
| Chen, S | 1 |
| Savransky, A | 1 |
| Marshall, W | 1 |
| Ryan, MC | 1 |
| Bruce, HA | 1 |
| Shuldiner, AR | 1 |
| Mitchell, BD | 1 |
| Kochunov, P | 1 |
| Hong, LE | 1 |
| Lee, SH | 1 |
| de Marco, KC | 1 |
| Braga, GU | 1 |
| Barbosa, F | 1 |
| Alberton, M | 1 |
| Wu, P | 1 |
| Druyts, E | 1 |
| Briel, M | 1 |
| Mills, EJ | 1 |
| MELON, JM | 1 |
| SHIODA, M | 1 |
| Ozcan, V | 1 |
| Beşoğul, Y | 1 |
| Tünerir, B | 1 |
| Dernek, S | 1 |
| Erden, T | 1 |
| Ozdemir, C | 1 |
| Unal, O | 1 |
| Aslan, R | 1 |
| Kural, T | 1 |
| Testa, A | 1 |
| Spoto, B | 1 |
| Tripepi, G | 1 |
| Mallamaci, F | 1 |
| Malatino, L | 1 |
| Fatuzzo, P | 1 |
| Maas, R | 1 |
| Boeger, R | 1 |
| Zoccali, C | 1 |
| Tesauro, M | 1 |
| Thompson, WC | 1 |
| Rogliani, P | 1 |
| Qi, L | 1 |
| Chaudhary, PP | 1 |
| Moss, J | 1 |
| Hetet, G | 1 |
| Elbaz, A | 1 |
| Gariepy, J | 1 |
| Nicaud, V | 1 |
| Arveiler, D | 1 |
| Morrison, C | 1 |
| Kee, F | 1 |
| Evans, A | 1 |
| Simon, A | 1 |
| Amarenco, P | 1 |
| Cambien, F | 1 |
| Grandchamp, B | 1 |
| Schoger, GA | 1 |
| Sauer, A | 1 |
| Gavrilescu, S | 1 |
3 reviews available for aspartic acid and Cardiovascular Diseases
| Article | Year |
|---|---|
Targeting mitochondrial impairment for the treatment of cardiovascular diseases: From hypertension to ischemia-reperfusion injury, searching for new pharmacological targets.
Topics: Adenosine Triphosphate; Aspartic Acid; Cardiovascular Diseases; Humans; Hypertension; Malates; Mitoc | 2023 |
[Oxidative stress-mediated chemical modifications to biomacromolecules: mechanism and implication of modifications to human skin keratins and angiotensin II].
Topics: Aldehydes; Angiotensin II; Animals; Aspartic Acid; Cardiovascular Diseases; DNA; DNA Damage; Glutamy | 2013 |
Adverse events associated with individual statin treatments for cardiovascular disease: an indirect comparison meta-analysis.
Topics: Adult; Aged; Alanine Transaminase; Aspartic Acid; Cardiovascular Diseases; Creatinine; Diabetes Mell | 2012 |
3 trials available for aspartic acid and Cardiovascular Diseases
| Article | Year |
|---|---|
Metabolomics strategy comprehensively unveils the effect of catechins intervention on the biomarkers of exposure to acrylamide and biomarkers of cardiometabolic risk.
Topics: Acrylamide; Adult; Alanine; Animals; Antioxidants; Aspartic Acid; Biomarkers; Capsules; Cardiovascul | 2022 |
[The effect of glutamate and aspartate on myocardial protection at cardiopulmonary bypass].
Topics: Aspartic Acid; Cardioplegic Solutions; Cardiovascular Diseases; Coronary Artery Bypass; Creatine Kin | 2004 |
[Pharmacological bases of a cardiovascular treatment using Bascardial].
Topics: Amino Alcohols; Aspartic Acid; Cardiovascular Diseases; Clinical Trials as Topic; Drug Combinations; | 1976 |
9 other studies available for aspartic acid and Cardiovascular Diseases
| Article | Year |
|---|---|
Cardiovascular risks impact human brain
Topics: Adult; Aspartic Acid; Blood Pressure; Cardiovascular Diseases; Echo-Planar Imaging; Female; Gray Mat | 2019 |
Determination of the effects of eNOS gene polymorphisms (T-786C and Glu298Asp) on nitric oxide levels in a methylmercury-exposed population.
Topics: Adolescent; Adult; Aged; Aspartic Acid; Cardiovascular Diseases; Female; Glutamic Acid; Humans; Male | 2011 |
[Clinical trials of potassium aspartate and magnesium aspartate in cardiovascular diseases].
Topics: Aspartic Acid; Cardiovascular Diseases; Humans | 1960 |
[STUDIES ON ASPARTATES. 1. CLINICAL STUDIES].
Topics: Amino Acids; Aspartic Acid; Biomedical Research; Cardiovascular Diseases; Diabetes Mellitus; Humans; | 1963 |
The GLU298ASP variant of nitric oxide synthase interacts with asymmetric dimethyl arginine in determining cardiovascular mortality in patients with end-stage renal disease.
Topics: Adult; Aged; Amino Acid Substitution; Analysis of Variance; Arginine; Aspartic Acid; Cardiovascular | 2005 |
Intracellular processing of endothelial nitric oxide synthase isoforms associated with differences in severity of cardiopulmonary diseases: cleavage of proteins with aspartate vs. glutamate at position 298.
Topics: Animals; Aorta; Aspartic Acid; Cardiovascular Diseases; Cells, Cultured; COS Cells; Genotype; Glutam | 2000 |
Association studies between haemochromatosis gene mutations and the risk of cardiovascular diseases.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Arteriosclerosis; Aspartic Acid; Brain Infarction; Cardi | 2001 |
[Heart metabolism and therapeutic interference by Movicard].
Topics: Aspartic Acid; Cardiovascular Diseases; Heart Diseases; Humans; Myocardium; Water-Electrolyte Balanc | 1969 |
[On the use of K and Mg aspartate in the treatment of some cardiovascular diseases].
Topics: Aspartic Acid; Cardiovascular Diseases; Humans; Magnesium; Potassium | 1968 |